Handelsavisen
prelaunch
Companies Healthcare CYH
CY
CYH NYSE Medical Equipment & Supplies

Community Health Systems Inc

$2,92
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
392,5M USD
P/E
0,8x
EV / Rev
0,8x
Div yield
Op margin
11,9 %
ROE
-35,0 %
Net margin
4,1 %
Debt / equity
-6,96
Beta
52w range
Volume
Day range
Prev close
$2,78
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

COMMUNITY HEALTH SYSTEMS INC is classified under Healthcare / Medical Equipment & Supplies and appears not currently profitable on the latest normalized snapshot.

Business. Community Health Systems Inc (NYSE: CYH) is a healthcare company primarily engaged in the medical devices industry. The firm operates within the Medical Equipment, Supplies & Distribution industry group, focusing on the sale of medical equipment and supplies. Specific details regarding its operating segments and geographic presence are not provided. The company is listed on the New York Stock Exchange under the ticker symbol CYH.

Classification97 %
SectorHealthcare
Business sectorHealthcare Equipment & Supplies
Industry groupMedical Equipment, Supplies & Distribution
IndustryMedical Equipment & Supplies
ActivityMedical Devices
Generated · rules-based
Sell-side consensus
HOLD9 analysts
2 buy4 hold3 sell
Avg 12m price target3,39

Analyst recommendations

9 analysts · consensus Hold
Buy2
Hold4
Sell3
12-month price target
3,39
Consensus of sell-side coverage.
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
0,8x
P/E
Analysts
Hold
9 analysts · indicative
Ownership
AQR Capital Management, LLC
largest disclosed fund holder
Profitability
-35,0 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning CYH.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to CYH. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Community Health Systems Inc (NYSE: CYH) is a healthcare company primarily engaged in the medical devices industry. The firm operates within the Medical Equipment, Supplies & Distribution industry group, focusing on the sale of medical equipment and supplies. Specific details regarding its operating segments and geographic presence are not provided. The company is listed on the New York Stock Exchange under the ticker symbol CYH.

    Classification97 %
    SectorHealthcare
    Business sectorHealthcare Equipment & Supplies
    Industry groupMedical Equipment, Supplies & Distribution
    IndustryMedical Equipment & Supplies
    ActivityMedical Devices
    AI synthesis
    GENERATED

    COMMUNITY HEALTH SYSTEMS INC (CYH) is currently classified as Medical Devices within Medical Equipment & Supplies (Healthcare). Classification confidence: 0.97 (rule-based classification). Capital structure on the latest snapshot: total assets 13,180,000,000 USD, total equity -1,454,000,000, short-term debt 0, long-term debt 10,127,000,000. Net cash position is approximately -9,415,000,000 USD. Self-calculated market cap is 392,498,101 USD (market_price × shares_outstanding_diluted). Profitability profile: revenue 2,965,000,000, gross profit 0, operating income 281,000,000, net income -58,000,000. Return on equity ~-35.0%. Return on assets ~3.9%. Operating-cash-flow to net-income ratio is 1.07. Risk profile from automated assessment: liquidity risk medium, dilution risk medium. Flags: Net cash is negative after subtracting total debt.; Source documents mention dilution or offering risk.. Recent news context: [TRIGGER] 8-K: 8-K (sec_8k_material) on CYH — filing_type=8-K; max_severity=medium; ignored_items=['7.01', '9.01']; material_items=['2.02']; all_items_found=['2.02', '7.01', '9.01']; severity_per_code={'2.02': 'medium'}; contributing_watchers=sec_8k_material (source=sec_8k_material; url=0001193125-26-312454). Additional context: 8-K: filing_type=8-K; max_severity=medium; ignored_items=['7.01', '9.01']; material_items=['2.02']; all_items_found=['2.02', '7.01', '9.01']; severity_per_code={'2.02': 'medium'}; contributing_watchers=sec_8k_material.

    Key takeaways
    • Observed GAAP P/E is about 0.77x.
    • Return on equity is about -35.0%.
    • Debt to equity is about -6.96x.
    • [TRIGGER] 8-K: 8-K (sec_8k_material) on CYH — filing_type=8-K; max_severity=medium; ignored_items=['7.01', '9.01']; material_items=['2.02']; all_items_found=['2.02', '7.01', '9.01']; severity_per_code={'2.02': 'medium'}; contributing_watchers=sec_8k_material (source=sec_8k_material; url=0001193125-26-312454)
    • Companyfacts coverage was partial; recent filing facts backfilled intangible_assets.
    • 10-Q 0001108109 false Q1 --12-31 http://fasb.org/us-gaap/2025#AssetImpairmentCharges http://fasb.org/us-gaap/2025#AssetImpairmentCharges P10Y 2021 2022 0.06875 0.06875 5.25 5.25 0.0475 0.0475 .10875 .10875 10.750 10.750 9.750 9.750 0.06875 0.06875 0.06125 0.06125 http://fasb.org/us-gaap/2025#OtherAssetsNoncurrent http://fasb.org/us-gaap/2025#OtherAssetsNoncurrent http://fasb.org/us-gaap/2025#LongTermDebtAndCapitalLeaseObligationsCurrent http://fasb.org/us-gaap/2025#LongTermDebtAndCapitalLeaseObligationsCurrent http://fasb.org/us-gaap/2025#LongTermDebtNoncurrent http://fasb.org/us-gaap/2025#LongTermDebtNoncurrent 1 http://fasb.org/srt/2025#ChiefExecutiveOfficerMember 0001108109 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001108109 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001108109 cyh:SeniorSecuredNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesAt975Due2034Member 2026-03-31 0001108109 2026-04-16 0001108109 cyh:CedarParkRegionalMedicalCenterMember 2025-12-31 0001108109 us-gaap:EmployeeStockOptionMember 2025-12-31 0001108109 cyh:ShorePointHealthPuntaGordMember 2025-12-31 0001108109 cyh:NorthwestHealthPhysiciansSpecialtyHospitalMember 2025-01-01 2025-12-31 0001108109 cyh:OtherMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt1075Due2033Member 2026-01-01 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt525Due2030Member 2026-03-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAtFourPointSevenFiveDue2031Member 2026-03-31 0001108109 cyh:FinanceLeaseRightOfUseAssetsMember 2025-12-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:AblFacilityAndOtherDebtMember 2026-03-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAtFourPointSevenFiveDue2031Member 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt10875Due2032Member 2025-12-31 0001108109 cyh:JuniorPrioritySecuredNotesMember cyh:SixPointEightSevenFivePercentageJuniorPrioritySecuredNotesDue2029Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt6Due2029Member 2026-01-01 2026-03-31 0001108109 cyh:PerformanceBasedAwardsGrantedOnOrAfterMarch12018Member cyh:ChiefExecutiveOfficerAndChiefFinancialOfficerMember cyh:RestrictedStockPerformanceBasedUnitsMember 2026-03-01 2026-03-31 0001108109 cyh:JuniorPrioritySecuredNotesMember cyh:JuniorPrioritySecuredNotesAt6125PercentDue2030Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-03-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:JuniorPrioritySecuredNotesMember cyh:SixPointEightSevenFivePercentageJuniorPrioritySecuredNotesDue2029Member 2025-12-31 0001108109 cyh:JuniorPrioritySecuredNotesMember cyh:SixPointEightSevenFivePercentageJuniorPrioritySecuredNotesDue2029Member 2025-12-31 0001108109 us-gaap:RestrictedStockUnitsRSUMember cyh:PlanTwoThousandNineMember srt:DirectorMember 2025-03-01 2025-03-01 0001108109 cyh:SiloamSpringsArkansasMember cyh:NorthwestMedicalCenterMember 2026-05-03 0001108109 cyh:SeniorSecuredNotesAtNinePointSevenFiveZeroDue2034Member cyh:SeniorSecuredNotesMember 2026-03-31 0001108109 us-gaap:LetterOfCreditMember cyh:AssetBasedLoanFacilityMember 2026-01-01 2026-03-31 0001108109 us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001108109 cyh:JuniorPrioritySecuredNotesMember cyh:JuniorPrioritySecuredNotesAt6125PercentDue2030Member 2025-12-31 0001108109 us-gaap:RetainedEarningsMember 2025-12-31 0001108109 cyh:JuniorPrioritySecuredNotesMember cyh:JuniorPrioritySecuredNotesAt6125PercentDue2030Member 2025-01-01 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt1075Due2033Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-03-31 0001108109 cyh:MeritHealthMadisonMember 2025-01-01 2025-12-31 0001108109 us-gaap:CommonStockMember 2025-12-31 0001108109 cyh:AdjustmentForCarryingValueOfOtherLongLivedAssetsAtUnderperformingHospitalsMember 2026-01-01 2026-03-31 0001108109 cyh:RedeemableNoncontrollingInterestsMember 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorNotesAt10875PercentDue2032Member 2026-02-02 2026-02-02 0001108109 cyh:SeniorSecuredNotesAtNinePointSevenFiveZeroDue2034Member cyh:SeniorSecuredNotesMember 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorNotesAt10875PercentDue2032Member 2026-03-31 0001108109 us-gaap:LetterOfCreditMember cyh:AmendedAndRestatedABLCreditAgreementMember 2024-06-05 0001108109 cyh:MedicaidMember 2025-01-01 2025-03-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:JuniorPrioritySecuredNotesMember cyh:SixPointEightSevenFivePercentageJuniorPrioritySecuredNotesDue2029Member 2026-03-31 0001108109 cyh:MedicareMember 2025-01-01 2025-03-31 0001108109 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesAtNinePointSevenFiveZeroDue2034Member cyh:SeniorSecuredNotesMember 2025-01-01 2025-12-31 0001108109 cyh:RedeemableNoncontrollingInterestsMember 2026-03-31 0001108109 cyh:FinanceLeaseAndFinancingObligationsMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt10875Due2032Member 2025-01-01 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt1075Due2033Member 2025-12-31 0001108109 us-gaap:NoncontrollingInterestMember 2026-01-01 2026-03-31 0001108109 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001108109 us-gaap:NoncontrollingInterestMember 2024-12-31 0001108109 cyh:RegionalHospitalOfScrantonMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt1075Due2033Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt975Due2034Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-12-31 0001108109 us-gaap:DomesticCountryMember 2026-01-01 2026-03-31 0001108109 cyh:WilkesBarreGeneralHospitalMember 2026-01-01 2026-03-31 0001108109 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001108109 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt6Due2029Member 2026-03-31 0001108109 us-gaap:RestrictedStockUnitsRSUMember cyh:PlanTwoThousandNineMember srt:DirectorMember 2025-03-01 2025-03-31 0001108109 cyh:OtherProbableContingenciesMember us-gaap:PendingLitigationMember 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt1075Due2033Member 2026-03-31 0001108109 cyh:FinanceLeaseRightOfUseAssetsMember us-gaap:BuildingAndBuildingImprovementsMember 2026-03-31 0001108109 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001108109 2025-10-01 2025-12-31 0001108109 cyh:SpringdaleArkansasMember cyh:NorthwestMedicalCenterMember 2026-05-03 0001108109 cyh:ShorePointHealthPuntaGordMember 2025-01-01 2025-12-31 0001108109 cyh:MeritHealthMadisonMember 2025-12-31 0001108109 cyh:AdjustmentForCarryingValueOfOtherLongLivedAssetsAtUnderperformingHospitalsMember 2025-01-01 2025-03-31 0001108109 cyh:FinanceLeaseRightOfUseAssetsMember us-gaap:FurnitureAndFixturesMember 2025-12-31 0001108109 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAtFourPointSevenFiveDue2031Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-03-31 0001108109 us-gaap:CommonStockMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt525Due2030Member 2025-12-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt10875Due2032Member 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAtFourPointSevenFiveDue2031Member 2026-01-01 2026-03-31 0001108109 cyh:JuniorPrioritySecuredNotesMember cyh:JuniorPrioritySecuredNotesAt6125PercentDue2030Member 2026-01-01 2026-03-31 0001108109 us-gaap:CommonStockMember 2024-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt10875Due2032Member 2026-01-01 2026-03-31 0001108109 2026-01-01 2026-03-31 0001108109 cyh:LakeNormanRegionalMedicalCenterMember 2025-01-01 2025-12-31 0001108109 cyh:PlanTwoThousandNineMember 2026-01-01 2026-03-31 0001108109 2025-01-01 2025-03-31 0001108109 cyh:SeniorSecuredNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesAt1075Due2033Member 2026-03-31 0001108109 cyh:MedicareManagedCareMember 2026-01-01 2026-03-31 0001108109 cyh:MeritHealthBiloxiAndMeritHealthMadisonMember 2026-01-01 2026-03-31 0001108109 cyh:ManagedCareAndOtherThirdPartyPayorsMember 2025-01-01 2025-03-31 0001108109 cyh:ShorePointHealthPortCharlotteMember 2025-01-01 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:DebtInstrumentRedemptionPeriodMember cyh:SeniorNotesAt10875PercentDue2032Member 2026-02-02 0001108109 cyh:RedeemableNoncontrollingInterestsMember 2026-01-01 2026-03-31 0001108109 cyh:JuniorPrioritySecuredNotesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember cyh:JuniorPrioritySecuredNotesAt6125PercentDue2030Member 2025-12-31 0001108109 cyh:TennovaHealthcare-ClarksvilleMember 2026-01-01 2026-03-31 0001108109 srt:MaximumMember 2026-01-01 2026-03-31 0001108109 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001108109 stpr:TN cyh:MeritHealthBiloxiMember 2026-03-31 0001108109 us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-03-31 0001108109 cyh:AblFacilityAndOtherDebtMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-03-31 0001108109 cyh:ShorePointHealthPortCharlotteMember 2025-12-31 0001108109 cyh:FinanceLeaseRightOfUseAssetsMember us-gaap:FurnitureAndFixturesMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAtSixDue2029Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-03-31 0001108109 cyh:RestrictedStockAndRestrictedStockUnitsMember 2026-01-01 2026-03-31 0001108109 cyh:AblFacilityCustomaryCovenantsMember cyh:AssetBasedLoanFacilityMember 2026-01-01 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAtSixDue2029Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-12-31 0001108109 us-gaap:NoncontrollingInterestMember 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt10875Due2032Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-03-31 0001108109 2024-12-31 0001108109 us-gaap:RetainedEarningsMember 2025-03-31 0001108109 cyh:RedeemableNoncontrollingInterestsMember 2025-01-01 2025-03-31 0001108109 cyh:AssetBasedLoanFacilityMember 2025-12-31 0001108109 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0001108109 cyh:RestrictedStockPerformanceBasedUnitsMember 2026-01-01 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt10875Due2032Member 2026-03-31 0001108109 2024-07-01 2024-09-30 0001108109 cyh:RedeemableNoncontrollingInterestsMember 2025-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt6Due2029Member 2025-12-31 0001108109 cyh:HospitalsSoldOrDeemedHeldForSaleMember 2025-01-01 2025-03-31 0001108109 2025-12-31 0001108109 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001108109 us-gaap:RestrictedStockUnitsRSUMember 2025-12-31 0001108109 srt:MaximumMember 2025-01-01 2025-03-31 0001108109 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001108109 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2026-01-01 2026-03-31 0001108109 cyh:AssetBasedLoanFacilityMember 2026-03-31 0001108109 cyh:OtherMember 2025-12-31 0001108109 cyh:JuniorPrioritySecuredNotesMember cyh:SixPointEightSevenFivePercentageJuniorPrioritySecuredNotesDue2029Member 2026-03-31 0001108109 cyh:MosesTaylorHospitalMember 2026-01-01 2026-03-31 0001108109 cyh:CrestwoodMedicalCenterMember cyh:HuntsvilleAlabamaMember 2026-01-20 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2026-03-31 0001108109 cyh:MosesTaylorHospitalMember 2026-03-31 0001108109 cyh:MedicareManagedCareMember 2025-01-01 2025-03-31 0001108109 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-03-31 0001108109 us-gaap:SeniorNotesMember cyh:SeniorNotesAt6875PercentDue2028Member 2026-01-01 2026-03-31 0001108109 us-gaap:NoncontrollingInterestMember 2026-03-31 0001108109 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-03-31 0001108109 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001108109 us-gaap:RestrictedStockUnitsRSUMember cyh:PlanTwoThousandNineMember srt:DirectorMember 2026-03-01 2026-03-31 0001108109 cyh:AmendedAndRestatedABLCreditAgreementMember 2024-06-05 0001108109 cyh:CrestwoodMedicalCenterMember cyh:HuntsvilleAlabamaMember us-gaap:SubsequentEventMember 2026-04-01 2026-04-01 0001108109 srt:MaximumMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesAtSixDue2029Member 2025-12-31 0001108109 cyh:AblFacilityAndOtherDebtMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-12-31 0001108109 us-gaap:SeniorNotesMember cyh:SeniorNotesAt6875PercentDue2028Member 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt10875Due2032Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAtFourPointSevenFiveDue2031Member 2025-01-01 2025-12-31 0001108109 cyh:MedicaidMember 2026-01-01 2026-03-31 0001108109 us-gaap:RetainedEarningsMember 2026-03-31 0001108109 us-gaap:RestrictedStockUnitsRSUMember 2026-03-31 0001108109 us-gaap:EmployeeStockOptionMember 2025-09-30 0001108109 cyh:LakeNormanRegionalMedicalCenterMember 2025-12-31 0001108109 cyh:AblFacilityCustomaryCovenantsMember cyh:AssetBasedLoanFacilityMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt525Due2030Member 2025-01-01 2025-12-31 0001108109 us-gaap:SeniorNotesMember cyh:SeniorNotesAt6875PercentDue2028Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesAt1075Due2033Member 2025-12-31 0001108109 us-gaap:RestrictedStockUnitsRSUMember 2025-03-01 2025-03-01 0001108109 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-03-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember cyh:SeniorNotesAt6875PercentDue2028Member 2025-12-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:JuniorPrioritySecuredNotesMember cyh:JuniorPrioritySecuredNotesAt6125PercentDue2030Member 2025-12-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2025-12-31 0001108109 cyh:TennovaHealthcare-ClarksvilleMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt1075Due2033Member 2025-01-01 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember cyh:SeniorSecuredNotesAt525Due2030Member 2026-03-31 0001108109 cyh:CedarParkRegionalMedicalCenterMember 2025-01-01 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorNotesAt10875PercentDue2032Member 2026-02-02 0001108109 us-gaap:CommonStockMember 2025-03-31 0001108109 us-gaap:RestrictedStockUnitsRSUMember 2026-03-01 2026-03-01 0001108109 cyh:SharedServiceCenterMember 2026-01-01 2026-03-31 0001108109 cyh:RestrictedStockAndRestrictedStockUnitsMember 2026-03-31 0001108109 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001108109 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001108109 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001108109 cyh:SelfPayRevenueMember 2025-01-01 2025-03-31 0001108109 cyh:OtherProbableContingenciesMember us-gaap:PendingLitigationMember 2026-03-31 0001108109 cyh:MeritHealthBiloxiMember 2025-01-01 2025-12-31 0001108109 cyh:NorthwestHealthPhysiciansSpecialtyHospitalMember 2025-12-31 0001108109 us-gaap:SeniorNotesMember cyh:SeniorNotesAt6875PercentDue2028Member 2025-01-01 2025-12-31 0001108109 cyh:FinanceLeaseRightOfUseAssetsMember 2026-03-31 0001108109 cyh:JuniorPrioritySecuredNotesMember cyh:SixPointEightSevenFivePercentageJuniorPrioritySecuredNotesDue2029Member 2025-01-01 2025-12-31 0001108109 us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001108109 us-gaap:RestrictedStockMember 2026-01-01 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt6Due2029Member 2025-01-01 2025-12-31 0001108109 cyh:MedicareMember 2026-01-01 2026-03-31 0001108109 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001108109 cyh:NorthwestMedicalCenterMember cyh:JohnsonArkansasMember 2026-05-03 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAtFourPointSevenFiveDue2031Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-12-31 0001108109 2025-03-31 0001108109 cyh:TennovaHealthcareMember 2025-01-01 2025-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt975Due2034Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-03-31 0001108109 cyh:ManagedCareAndOtherThirdPartyPayorsMember 2026-01-01 2026-03-31 0001108109 cyh:PerformanceBasedAwardsGrantedOnOrAfterMarch12018Member cyh:RestrictedStockPerformanceBasedUnitsMember cyh:OtherSeniorExecutivesMember 2026-03-01 2026-03-31 0001108109 us-gaap:SeniorNotesMember cyh:SeniorNotesAt6875PercentDue2028Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-03-31 0001108109 cyh:FinanceLeaseAndFinancingObligationsMember 2025-12-31 0001108109 us-gaap:EmployeeStockOptionMember 2026-03-31 0001108109 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001108109 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-12-31 0001108109 cyh:FinanceLeaseRightOfUseAssetsMember us-gaap:BuildingAndBuildingImprovementsMember 2025-12-31 0001108109 cyh:CrestwoodMedicalCenterMember us-gaap:SubsequentEventMember cyh:HuntsvilleAlabamaMember 2026-04-01 0001108109 cyh:SeniorSecuredNotesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember cyh:SeniorSecuredNotesAt525Due2030Member 2025-12-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:AblFacilityAndOtherDebtMember 2025-12-31 0001108109 us-gaap:RestrictedStockMember 2025-12-31 0001108109 cyh:RegionalHospitalOfScrantonMember 2026-01-01 2026-03-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt975Due2034Member 2025-12-31 0001108109 cyh:WilkesBarreGeneralHospitalMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorNotesAt10875PercentDue2032Member 2025-12-31 0001108109 us-gaap:SeniorNotesMember cyh:SeniorNotesAt6875PercentDue2028Member 2026-03-31 0001108109 us-gaap:RestrictedStockUnitsRSUMember cyh:PlanTwoThousandNineMember srt:DirectorMember 2026-03-01 2026-03-01 0001108109 cyh:HospitalsSoldOrDeemedHeldForSaleMember 2026-01-01 2026-03-31 0001108109 cyh:OtherProbableContingenciesMember us-gaap:PendingLitigationMember 2026-01-01 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt525Due2030Member 2026-01-01 2026-03-31 0001108109 us-gaap:RetainedEarningsMember 2024-12-31 0001108109 cyh:MeritHealthBiloxiMember 2025-12-31 0001108109 us-gaap:LetterOfCreditMember cyh:AssetBasedLoanFacilityMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesAtSixDue2029Member 2026-03-31 0001108109 cyh:RedeemableNoncontrollingInterestsMember 2024-12-31 0001108109 cyh:JuniorPrioritySecuredNotesMember cyh:SixPointEightSevenFivePercentageJuniorPrioritySecuredNotesDue2029Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-03-31 0001108109 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAtNinePointSevenFiveZeroDue2034Member 2026-01-01 2026-03-31 0001108109 us-gaap:NoncontrollingInterestMember 2025-03-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt10875Due2032Member 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesAt525Due2030Member 2025-12-31 0001108109 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-03-31 0001108109 us-gaap:SeniorNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorNotesAt6875PercentDue2028Member 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAtFourPointSevenFiveDue2031Member 2026-03-31 0001108109 us-gaap:RestrictedStockMember 2026-03-31 0001108109 cyh:SelfPayRevenueMember 2026-01-01 2026-03-31 0001108109 cyh:JuniorPrioritySecuredNotesMember cyh:SixPointEightSevenFivePercentageJuniorPrioritySecuredNotesDue2029Member 2026-01-01 2026-03-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt525Due2030Member 2026-03-31 0001108109 cyh:PlanTwoThousandNineMember 2026-03-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:JuniorPrioritySecuredNotesMember cyh:JuniorPrioritySecuredNotesAt6125PercentDue2030Member 2026-03-31 0001108109 cyh:JuniorPrioritySecuredNotesMember cyh:JuniorPrioritySecuredNotesAt6125PercentDue2030Member 2026-03-31 0001108109 cyh:BentonvilleArkansasMember cyh:NorthwestMedicalCenterMember 2026-05-03 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAtFourPointSevenFiveDue2031Member 2025-12-31 cyh:Hospital xbrli:pure cyh:Item xbrli:shares cyh:Segment cyh:Director iso4217:USD iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 4

    Community Health Systems generated $1.49 billion in operating income for fiscal year 2025, demonstrating strong core profitability.

    The company achieved a positive net income of $509 million in fiscal year 2025, marking a significant turnaround.

    Free cash flow improved to $208 million in fiscal year 2025, providing liquidity for debt reduction and operations.

    Return on invested capital of 17.2% suggests the company generates substantial value relative to its capital base.

    BEAR CASE · 4

    High credit risk is flagged, compounded by a net debt to EBITDA ratio of 5.29, signaling leverage concerns.

    Negative book value of -$4.1 billion indicates substantial accumulated losses eroding the company's equity base.

    Medium liquidity risk is identified, suggesting potential challenges in meeting short-term financial obligations comfortably.

    Revenue growth remained sluggish with a 0.6% CAGR from 2023 to 2025, limiting top-line expansion potential.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-03-31
    Q4 2025 · Quarter highlights
    Open report →

    Revenue $2.96B; Operating income $281.0M.

    Revenue$2.96B
    Operating income$281.0M
    Net income-$58.0M
    Free cash flow-$373.0M
    EPS
    Operating cash flow-$297.0M
    Financials
    Income statement
    Revenue$2.96B
    Gross profit
    Operating income$281.0M
    Net income-$58.0M
    Margins
    Gross margin
    Operating margin9.5%
    Net margin-2.0%
    FCF margin-12.6%
    Balance sheet
    Total assets$13.18B
    Total liabilities$14.14B
    Total equity-$1.45B
    Cash & equivalents$712.0M
    Long-term debt$10.13B
    Cash flow
    Operating cash flow-$297.0M
    CapEx$76.0M
    Free cash flow-$373.0M
    SBC$3.0M
    P&L flow · revenue → net income
    Revenue $2.96BOperating costs $2.68BTax $339.0MNet income $58.0M
    Highlights
    • Revenue $2.96B
    • Operating income $281.0M
    • Net margin -2.0%

    Valuation FY

    Market price
    $2,92
    Market cap
    $392.5M
    Enterprise value
    $9.81B
    P/E
    0.8x
    Non-GAAP P/E
    EV / Revenue
    0.8x
    EV / Op income
    6.6x
    EV / OCF
    18.1x
    P / B
    P / Tangible book
    Tangible book
    -$4.10B
    Net cash
    -$9.41B
    Current ratio
    1.5
    Debt / equity
    -7.0
    ROA
    3.9%
    ROE
    -35.0%
    Cash conversion
    107.0%
    CapEx / revenue
    2.7%
    SBC / revenue
    0.1%
    Dilution ratio
    -4.6%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution9 analysts
    Strong buy1
    Buy1
    Hold5
    Sell2
    Strong sell0
    12-month price target$3,31 · Median $3,00
    Low $2,00High $5,00
    Operating income · consensus965,1M USD
    EPS surprise
    +284,5 %
    reported vs consensus · beat
    Revenue surprise
    +7,5 %
    reported vs consensus · beat

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$2,00
    Mean$3,39
    Median$3,50
    High$5,00
    Spot$2,92
    +16.2 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskMedium
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.
    • Source documents mention dilution or offering risk.

    Benchmarks vs cohort

    Op Margin11,9 %Above median
    Net Margin4,1 %Above median
    ROE-35,0 %Below median
    Capex / Rev2,7 %Below median
    D/E-6,96Best in class
    Cash Conv1,07Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net acquired 1 165 218 sh27 exercises · 25 grants19 insiders
    • Krishnan K RangaDirector · Stock Units (SU) → Common StockDisposed 13 931exercise · 2026-06-30
    • Rice David V.EVP-Clinical Operations & CMO · Stock Options (Right to Buy) → Common StockAcquired 30 000 @ $2,75grant · 2026-06-01
    • Rice David V.EVP-Clinical Operations & CMO · Performance Based Restricted → Common StockAcquired 30 000grant · 2026-06-01
    • Krishnan K RangaDirector · Restricted Stock Units → Common StockDisposed 46 950exercise · 2026-04-22
    • DINKINS MICHAELDirector · Restricted Stock Units → Common StockAcquired 52 023grant · 2026-03-01
    • Brooks Susan WDirector · Restricted Stock Units → Common StockDisposed 9 756exercise · 2026-03-01
    • STOCKTON KEVIN AEVP, Operations & Development · Performance Based Restricted → Common StockDisposed 50 000exercise · 2026-03-01
    • STOCKTON KEVIN AEVP, Operations & Development · Performance Based Restricted → Common StockAcquired 60 000grant · 2026-03-01
    • STOCKTON KEVIN AEVP, Operations & Development · Stock Options (Right to Buy) → Common StockAcquired 30 000 @ $3,46grant · 2026-03-01
    • Posey Phillip A.SVP & CAO · Performance Based Restricted → Common StockAcquired 25 000grant · 2026-03-01
    • Posey Phillip A.SVP & CAO · Stock Options (Right to Buy) → Common StockAcquired 25 000 @ $3,46grant · 2026-03-01
    • Pitt Justin DPres,Chief Legal&Admin Officer · Performance Based Restricted → Common StockDisposed 30 000exercise · 2026-03-01
    • Pitt Justin DPres,Chief Legal&Admin Officer · Performance Based Restricted → Common StockAcquired 80 000grant · 2026-03-01
    • Pitt Justin DPres,Chief Legal&Admin Officer · Stock Options (Right to Buy) → Common StockAcquired 40 000 @ $3,46grant · 2026-03-01
    • Ely James S. IIIDirector · Restricted Stock Units → Common StockDisposed 20 906exercise · 2026-03-01
    • Ely James S. IIIDirector · Restricted Stock Units → Common StockDisposed 19 933exercise · 2026-03-01
    • Ely James S. IIIDirector · Restricted Stock Units → Common StockAcquired 52 023grant · 2026-03-01
    • DINKINS MICHAELDirector · Restricted Stock Units → Common StockDisposed 9 756exercise · 2026-03-01
    • DINKINS MICHAELDirector · Restricted Stock Units → Common StockDisposed 20 906exercise · 2026-03-01
    • CLERICO JOHN ADirector · Restricted Stock Units → Common StockDisposed 9 756exercise · 2026-03-01
    • CLERICO JOHN ADirector · Restricted Stock Units → Common StockDisposed 20 906exercise · 2026-03-01
    • CLERICO JOHN ADirector · Restricted Stock Units → Common StockDisposed 19 933exercise · 2026-03-01
    • CLERICO JOHN ADirector · Restricted Stock Units → Common StockAcquired 52 023grant · 2026-03-01
    • BURGESS RONALD L JRDirector · Restricted Stock Units → Common StockAcquired 52 023grant · 2026-03-01
    • Brooks Susan WDirector · Restricted Stock Units → Common StockDisposed 20 906exercise · 2026-03-01

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Regulatory filings
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    • Reference data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Enterprise Value
      market_cap - net_cash
    • Ev To Revenue
      enterprise_value / revenue
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Capex To Revenue
      capital_expenditure / revenue
    Source documents
    • COMMUNITY HEALTH SYSTEMS INC company facts · 2026-07-26
    • COMMUNITY HEALTH SYSTEMS INC 10-Q 2026-04-22 · 2026-07-26
    • COMMUNITY HEALTH SYSTEMS INC 10-K 2026-02-19 · 2026-07-26
    • COMMUNITY HEALTH SYSTEMS INC 10-Q 2025-10-24 · 2026-07-26
    • COMMUNITY HEALTH SYSTEMS INC 10-Q 2025-07-24 · 2026-07-26
    • 8-K (sec_8k_material) on CYH · 2026-07-26
    • Community Health Systems Inc Market data — analyst estimates · 2026-07-26
    • Community Health Systems Inc Market data — ESG · 2026-07-26

    Ownership & reference

    Top holders

    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,00 %$4M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,00 %$7M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$8M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$8M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,00 %$31M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$9M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$4M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$29M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,00 %$2M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$9M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$5M
    • Invesco QQQ TrustFunds · as of 2026-03-310,00 %$1M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • LPL Financial LLCInvestment Managers · as of 2026-03-310,00 %$1M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,00 %$0M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,00 %$0M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$0M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,00 %$0M
    • Victory Capital Management Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • FMR LLCInstitutional Investor · as of 2026-03-310,00 %$0M

    Insider activity

    Mixed / flat0 buys · 0 sellsnet $015 insiders · last 365d
    • Krishnan K RangaDirector · Common StockOther 13 930 · 2026-06-30
    • Rice David V.EVP-Clinical Operations & CMO · Common StockOther 30 000 · 2026-06-01
    • Krishnan K RangaDirector · Common StockOther 46 950 · 2026-04-22
    • SMITH WAYNE TDirector · Common StockOther 19 400 · 2026-03-02
    • STOCKTON KEVIN AEVP, Operations & Development · Common StockOther 30 000 · 2026-03-01
    • STOCKTON KEVIN AEVP, Operations & Development · Common StockOther 35 573 @ $3,46$123K · 2026-03-01
    • Posey Phillip A.SVP & CAO · Common StockOther 25 000 · 2026-03-01
    • Posey Phillip A.SVP & CAO · Common StockOther 1 188 @ $3,46$4K · 2026-03-01
    • Pitt Justin DPres,Chief Legal&Admin Officer · Common StockOther 30 000 · 2026-03-01
    • Pitt Justin DPres,Chief Legal&Admin Officer · Common StockOther 40 000 · 2026-03-01
    • Pitt Justin DPres,Chief Legal&Admin Officer · Common StockOther 24 922 @ $3,46$86K · 2026-03-01
    • Johnson Jason KEVP & CFO · Common StockOther 30 000 · 2026-03-01
    • Johnson Jason KEVP & CFO · Common StockOther 90 000 · 2026-03-01
    • Johnson Jason KEVP & CFO · Common StockOther 23 610 @ $3,46$82K · 2026-03-01
    • HAMMONS KEVIN JCEO · Common StockOther 156 240 · 2026-03-01
    • HAMMONS KEVIN JCEO · Common StockOther 200 000 · 2026-03-01
    • HAMMONS KEVIN JCEO · Common StockOther 96 896 @ $3,46$335K · 2026-03-01
    • Williams Hubert JamesDirector · Common StockOther 9 756 · 2026-03-01
    • Williams Hubert JamesDirector · Common StockOther 20 906 · 2026-03-01
    • Williams Hubert JamesDirector · Common StockOther 19 933 · 2026-03-01
    • Hirsch Elizabeth TDirector · Common StockOther 20 906 · 2026-03-01
    • Hirsch Elizabeth TDirector · Common StockOther 19 933 · 2026-03-01
    • FRY JOHN ADirector · Common StockOther 9 756 · 2026-03-01
    • FRY JOHN ADirector · Common StockOther 20 906 · 2026-03-01
    • FRY JOHN ADirector · Common StockOther 19 933 · 2026-03-01

    Short positioning

    12.1Mshares short-0.8% vs prior
    5.45days to cover
    57.9%short of daily vol
    5.9Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    CYHCanonical
    NYSE · USD

    Intel & risk

    What changed

    no material change vs prior analysis (walked 17 fields; 4 schema-expansion field(s) excluded)

    • Narrative— → —medium
    • Conclusion— → —medium
    • Key takeaways— → —medium
    • Company share pct— → —medium
    vs prior analysis 2 days ago
    peak dispatch · —
    OSINT findings
    Dilution riskMedium
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Source documents mention dilution or offering risk.

    Evidence & claims

    From filings & derived data
    • Operating income (annual): USD 1.49BUnknown
    • Current assets (annual): USD 3.23BUnknown
    • Shares outstanding (annual): 138.63MUnknown
    • Cost of revenue (annual): USD 1.86BUnknown
    • Shareholders' equity (annual): USD -1.39BUnknown
    • Cash & equivalents (annual): USD 260MUnknown
    • Operating cash flow (annual): USD 543MUnknown
    • Long-term debt (annual): USD 10.4BUnknown
    • EPS (basic) (annual): USD-PER-SHARES 4Unknown
    • Total liabilities (annual): USD 14.04BUnknown
    • Total assets (annual): USD 13.2BUnknown
    • Capex (annual): USD 335MUnknown
    • EPS (diluted) (annual): USD-PER-SHARES 4Unknown
    • Net income (annual): USD 509MUnknown
    • Current liabilities (annual): USD 2.21BUnknown
    • Pre-tax income (annual): USD 724MUnknown
    • Revenue (annual): USD 12.48BUnknown
    • Operating cash flow (annual): USD 480MUnknown
    • EPS (diluted) (annual): USD-PER-SHARES -4Unknown
    • Capex (annual): USD 360MUnknown
    • Total assets (annual): USD 14.05BUnknown
    • Net income (annual): USD -516MUnknown
    • Cost of revenue (annual): USD 1.95BUnknown
    • Operating income (annual): USD 542MUnknown
    Showing 24 of 34 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-07-23 04:29 UTCFILINGMaterial 8-K
    2026-07-23EVENTQ2 2026 earnings (expected) estimated date
    2026-07-22 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
    2026-07-22EVENTQ2 2026 earnings (expected) estimated date
    2026-06-30INSIDERKrishnan K Ranga transacted 13.9k sh — Director
    2026-06-30INSIDERKrishnan K Ranga disposed of 13.9k sh Stock Units (SU) — Director
    2026-06-01 00:00 UTCINSIDER3 insider transactions — 2026-06 2 derivative
    2026-06-01FILING8-K filing →
    2026-06-01INSIDERRice David V. transacted 30.0k sh — EVP-Clinical Operations & CMO
    2026-06-01INSIDERRice David V. acquired 30.0k sh Stock Options (Right to Buy) — EVP-Clinical Operations & CMO
    2026-05-13FILING8-K filing →
    2026-05-06FILING8-K filing →
    2026-04-23FILING8-K filing →
    2026-04-22 00:00 UTCINSIDER2 insider transactions — 2026-04 1 derivative
    2026-04-22FILING10-Q filing →
    2026-04-22INSIDERKrishnan K Ranga transacted 47.0k sh — Director
    2026-04-22INSIDERKrishnan K Ranga disposed of 47.0k sh Restricted Stock Units — Director
    2026-04-21FILING8-K filing →
    2026-04-02FILINGDEF 14A filing →
    2026-04-01FILING8-K filing →
    2026-03-31EARNINGSQuarterly results — Q4 2025 Revenue USD 2.96B · Net USD -58.0M
    2026-03-05FILING8-K filing →
    2026-03-02 00:00 UTCINSIDER83 insider transactions — 2026-03 · net sell $630k 48 derivative
    2026-03-02INSIDERSMITH WAYNE T transacted 19.4k sh — Director
    2026-03-01INSIDERSTOCKTON KEVIN A transacted 30.0k sh — EVP, Operations & Development
    2026-03-01INSIDERSTOCKTON KEVIN A transacted 35.6k sh — EVP, Operations & Development ~$123k
    2026-03-01INSIDERPosey Phillip A. transacted 25.0k sh — SVP & CAO
    2026-03-01INSIDERPosey Phillip A. transacted 1.2k sh — SVP & CAO ~$4k
    2026-03-01INSIDERPitt Justin D transacted 30.0k sh — Pres,Chief Legal&Admin Officer
    2026-03-01INSIDERPitt Justin D transacted 40.0k sh — Pres,Chief Legal&Admin Officer
    2026-03-01INSIDERPitt Justin D transacted 24.9k sh — Pres,Chief Legal&Admin Officer ~$86k
    2026-03-01INSIDERJohnson Jason K transacted 30.0k sh — EVP & CFO
    2026-03-01INSIDERJohnson Jason K transacted 90.0k sh — EVP & CFO
    2026-03-01INSIDERJohnson Jason K transacted 23.6k sh — EVP & CFO ~$82k
    2026-03-01INSIDERHAMMONS KEVIN J transacted 156.2k sh — CEO
    2026-03-01INSIDERHAMMONS KEVIN J transacted 200.0k sh — CEO
    2026-03-01INSIDERHAMMONS KEVIN J transacted 96.9k sh — CEO ~$335k
    2026-03-01INSIDERWilliams Hubert James transacted 9.8k sh — Director
    2026-03-01INSIDERWilliams Hubert James transacted 20.9k sh — Director
    Showing the 40 most recent of 69 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data Premium coverage